Cardiovascular Risks of BTK Inhibitors: What Pharmacists Need to Know ByAlexandra Gerlach, Associate Editor,Sarah Spinler, PharmD, FCCP, FAHA, FASHP, AACCApril 1st 2025Sarah Spinler, PharmD, FCCP, FAHA, FASHP, AACC, discussed management of atrial fibrillation in patients with cancer.